EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Challenges and opportunities for proton therapy during pregnancy

Jeroen Blommaert, Marijke De Saint-Hubert, Tom Depuydt, Edwin Oldehinkel, Philip Poortmans, Frederic Amant, Maarten Lambrecht

Acta Obstetricia et Gynecologica Scandinavica · 2024

DOI: 10.1111/aogs.14645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2024. Verfasst von Jeroen Blommaert und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Proton Therapy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During pregnancy, the use of radiation therapy for cancer treatment is often considered impossible due to the assumed associated fetal risks. However, suboptimal treatment of pregnant cancer patients and unjustifiable delay in radiation therapy until after delivery can be harmful for both patient and child. In non‐pregnant patients, proton‐radiation therapy is increasingly administered because of its favorable dosimetric properties compared with photon‐radiation therapy. Although data on the use of pencil beam scanning proton‐radiation therapy during pregnancy are scarce, different case reports and dosimetric studies have indicated a more than 10‐fold reduction in fetal radiation exposure compared with photon‐radiation therapy. Nonetheless, the implementation of proton‐radiation therapy during pregnancy requires complex fetal dosimetry for the neutron‐dominated out‐of‐field radiation dose and faces a lack of clinical guidelines. Further exploration and standardization of proton‐radiation therapy during pregnancy will be necessary to improve radiotherapeutic management of pregnant women with cancer and further reduce risks for their offspring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton TherapyFemaleHumansPregnancyFetusNeutronsProtonsRadiometryRadiotherapy Dosage

Stichwörter der Autor:innen

cancerfetal radiationpregnancyproton therapyradiation therapy

Substanzen

Protons

Autor:innen und Institutionen

  • Department of Oncology, KU Leuven, Leuven, Belgium.
  • Belgium Nuclear Research Center, Mol, Belgium.
  • Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Radiation Oncology, Iridium Netwerk & University of Antwerp, Wilrijk, Belgium.
  • Gynecologic Oncology, Antoni van Leeuwenhoek, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Zitieren

APA

Blommaert, J., De Saint-Hubert, M., Depuydt, T., Oldehinkel, E., Poortmans, P., Amant, F., & Lambrecht, M. (2024). Challenges and opportunities for proton therapy during pregnancy. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14645

Vancouver

Blommaert J, De Saint-Hubert M, Depuydt T, Oldehinkel E, Poortmans P, Amant F, et al. Challenges and opportunities for proton therapy during pregnancy. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14645

BibTeX
@article{Blommaert2024,
  author = {Blommaert, Jeroen and De Saint-Hubert, Marijke and Depuydt, Tom and Oldehinkel, Edwin and Poortmans, Philip and Amant, Frederic and Lambrecht, Maarten},
  title = {Challenges and opportunities for proton therapy during pregnancy},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  doi = {10.1111/aogs.14645}
}
Kostenlos starten →